ReproCELL Incorporated

2026/08/20 Updated
Market Cap: $92.7M (¥14.7B)
Stock Price: $0.95 (¥150)
Exchange Rate: 1 USD = ¥158.48

Notice Regarding Application for Manufacturing and Marketing Approval of Stemchymal, a Cell Therapy Product for Spinocerebellar Ataxia Types 3 and 6 in Japan

Importance:
Page Updated: June 24, 2026
IR Disclosure Date: June 24, 2026
その他

G-リプロセル

Company overview · Stock price · Financial data · All IR

View company page →